Changes of Alternative Splice Variant of the SRSF12 by Cisplatin in Multiple Cells
10.3969/j.issn.1003-4706.2018.01.002
- VernacularTitle:顺铂处理后剪接因子SRSF12 mRNA异构体在多种细胞中的变化
- Author:
Chun-Xia MA
1
;
Ming-Yang LI
;
Han-Xin WU
;
Yuan YANG
;
Meng-Li YANG
;
Jian-Kun YU
Author Information
1. 中国医学科学院医学生物学研究所
- Keywords:
CDDP;
Arginine-serine rich splicing factor12;
mRNA alternative splicing ( AS);
Tissue-specific;
Cell type-specific
- From:
Journal of Kunming Medical University
2018;39(1):5-9
- CountryChina
- Language:Chinese
-
Abstract:
Objective To detect the changes of mRNA isoforms in multiple cancer cell lines with dose of cisplatin. Methods Total RNA of the cells treated by cisplatin were abstracted 24 h after the treatment. mRNA isoforms of SRSF12 gene were detected by semiquantitative RT-PCR. The ratios of mRNA isoforms were analyzed by gel image software and statistical analysis. Results Under the cisplatin treatment, 2 mRNA isoforms of SRSF12 were detected in five cells except Caski cells,their ratios and relative mRNA levels were changed. With the increase of dose of cisplatin, the ratio of isoform-a was slightly increased; but the ratio of isoform-b was different, the changes were not obvious in the A549 and 293FT cells, the weaker expression was expressed in the H1299 and C33A cells, and the two isoforms were gradually weakening in the Siha cells. Conclution Under the cisplatin treatment in multiple cancer cells, the expression of SRSF12 shows tissue-specific and cell type-specific patterns .
